Abstract
Periprosthetic joint infection (PJI) is a relatively rare but potentially devastating consequence of total hip arthroplasty (THA) and total knee arthroplasty (TKA). Patient risk factors include uncontrolled diabetes, morbid obesity, rheumatoid arthritis, cirrhosis, hepatitis C, immunosuppressive medications, smoking, human immunodeficiency virus infection, and alcohol abuse. Perioperative risk factors include use of perioperative antibiotics, surgical site preparation, surgical attire, and operating room conditions. PJI diagnosis should be based on clinical judgement and incorporate information from the patient’s history and physical exam, serological testing, synovial fluid analysis, radiographic assessment, and microbiologic and histopathologic testing. There are four main types of PJI: early postoperative, late chronic, acute hematogenous, and positive intraoperative cultures at the time of revision for presumed aseptic loosening. Treatment depends on the type of infection, with debridement, antibiotics, and implant retention generally recommended for early postoperative and acute hematogenous infections; single- or two-stage revisions for chronic infections; and antimicrobial therapy without revision for unexpectedly positive cultures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780–5.
Dale H, Hallan G, Espehaug B, Havelin LI, Engesaeter LB. Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop. 2009;80(6):639–45.
Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010;468(1):52–6.
Yokoe DS, Avery TR, Platt R, Huang SS. Reporting surgical site infections following total hip and knee arthroplasty: impact of limiting surveillance to the operative hospital. Clin Infect Dis. 2013;57(9):1282–8.
Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic burden of periprosthetic joint infection in the United States. J Arthroplast. 2012;27(8 Suppl):61–5.
Parisi TJ, Konopka JF, Bedair HS. What is the long-term economic societal effect of periprosthetic infections after THA? A Markov analysis. Clin Orthop Relat Res. 2017;475(7):1891–900.
Kong L, Cao J, Zhang Y, Ding W, Shen Y. Risk factors for periprosthetic joint infection following primary total hip or knee arthroplasty: a meta-analysis. Int Wound J. 2017;14(3):529–36.
Jiang SL, Schairer WW, Bozic KJ. Increased rates of periprosthetic joint infection in patients with cirrhosis undergoing total joint arthroplasty. Clin Orthop Relat Res. 2014;472(8):2483–91.
Goodman SM, Springer B, Guyatt G, Abdel MP, Dasa V, George M, et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of anti-rheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. J Arthroplast. 2017;32(9):2628–38.
Pour AE, Matar WY, Jafari SM, Purtill JJ, Austin MS, Parvizi J. Total joint arthroplasty in patients with hepatitis C. J Bone Joint Surg Am. 2011;93(15):1448–54.
Marmor S, Kerroumi Y. Patient-specific risk factors for infection in arthroplasty procedure. Orthop Traumatol Surg Res. 2016;102(1 Suppl):113–9.
Schrama JC, Espehaug B, Hallan G, Engesaeter LB, Furnes O, Havelin LI, et al. Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register. Arthritis Care Res. 2010;62(4):473–9.
Kunutsor SK, Whitehouse MR, Blom AW, Beswick AD, INFORM Team. Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0150866.
Tarabichi M, Shohat N, Kheir MM, Adelani M, Brigati D, Kearns SM, et al. Determining the threshold for HbA1c as a predictor for adverse outcomes after total joint arthroplasty: a multicenter, retrospective study. J Arthroplast. 2017;32(9 Suppl):263–7.
Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP, et al. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am. 2012;94(9):794–800.
Dowsey MM, Choong PF. Obese diabetic patients are at substantial risk for deep infection after primary TKA. Clin Orthop Relat Res. 2009;467(6):1577–81.
Alamanda VK, Springer BD. Perioperative and modifiable risk factors for periprosthetic joint infections (PJI) and recommended guidelines. Curr Rev Musculoskelet Med. 2018;11(3):325–31.
Golomb I, Ben David M, Glass A, Kolitz T, Keidar A. Long-term metabolic effects of laparoscopic sleeve gastrectomy. JAMA Surg. 2015;150(11):1051–7.
Werner BC, Kurkis GM, Gwathmey FW, Browne JA. Bariatric surgery prior to total knee arthroplasty is associated with fewer postoperative complications. J Arthroplast. 2015;30(9 Suppl):81–5.
Inacio MC, Paxton EW, Fisher D, Li RA, Barber TC, Singh JA. Bariatric surgery prior to total joint arthroplasty may not provide dramatic improvements in post-arthroplasty surgical outcomes. J Arthroplast. 2014;29(7):1359–64.
Martin JR, Watts CD, Taunton MJ. Bariatric surgery does not improve outcomes in patients undergoing primary total knee arthroplasty. Bone Joint J. 2015;97(11):1501–5.
Via M. The malnutrition of obesity: micronutrient deficiencies that promote diabetes. ISRN Endocrinol. 2012;2012:103472.
Greene KA, Wilde AH, Stulberg BN. Preoperative nutritional status of total joint patients. Relationship to postoperative wound complications. J Arthroplast. 1991;6(4):321–5.
Jaberi FM, Parvizi J, Haytmanek CT, Joshi A, Purtill J. Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty. Clin Orthop Relat Res. 2008;466(6):1368–71.
Sørensen LT. Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy: a systematic review. Ann Surg. 2012;255(6):1069–79.
Teng S, Yi C, Krettek C, Jagodzinski M. Smoking and risk of prosthesis-related complications after total hip arthroplasty: a meta-analysis of cohort studies. PLoS One. 2015;10(4):e0125294.
Tischler EH, Matsen Ko L, Chen AF, Maltenfort MG, Schroeder J, Austin MS. Smoking increases the rate of reoperation for infection within 90 days after primary total joint arthroplasty. J Bone Joint Surg Am. 2017;99(4):295–304.
Dimitriou D, Ramokgopa M, Pietrzak JRT, van der Jagt D, Mokete L. Human immunodeficiency virus infection and hip and knee arthroplasty. JBJS Rev. 2017;5(9):e8.
Boylan MR, Basu N, Naziri Q, Issa K, Maheshwari AV, Mont MA. Does HIV infection increase the risk of short-term adverse outcomes following total knee arthroplasty? J Arthroplast. 2015;30(9):1629–32.
Bradley KA, Rubinsky AD, Sun H, Blough DK, Tønnesen H, Hughes G, et al. Prevalence of alcohol misuse among men and women undergoing major noncardiac surgery in the veterans affairs health care system. Surgery. 2012;152(1):69–81.
Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10(3):505–20.
Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Infectious Diseases Society of America diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):e1–e25.
Sousa RJ, Barreira PM, Leite PT, Santos AC, Ramos MH, Oliveira AF. Preoperative Staphylococcus aureus screening/decolonization protocol before total joint arthroplasty-results of a small prospective randomized trial. J Arthroplast. 2016;31(1):234–9.
Sporer SM, Rogers T, Abella L. Methicillin-resistant and methicillin-sensitive Staphylococcus aureus screening and decolonization to reduce surgical site infection in elective total joint arthroplasty. J Arthroplast. 2016;31(9 Suppl):144–7.
Berbari EF, Osmon DR, Lahr B, Eckel-Passow JE, Tsaras G, Hanssen AD, et al. The Mayo prosthetic joint infection risk score: implication for surgical site infection reporting and risk stratification. Infect Control Hosp Epidemiol. 2012;33(8):774–81.
Boraiah S, Joo L, Inneh IA, Rathod P, Meftah M, Band P, et al. Management of modifiable risk factors prior to primary hip and knee arthroplasty: a readmission risk assessment tool. J Bone Joint Surg Am. 2015;97(23):1921–8.
Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev. 2014;27(2):302–45.
Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop. 2010;468:45–51.
Parvizi J, Tan TL, Goswami K, Higuera C, Della Valle C, Chen A, et al. The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criterion. J Arthoplasty. 2018;33:1309–14.
Parvizi J, Della Valle CJ. AAOS clinical practice guideline: diagnosis and treatment of periprosthetic joint infections of the hip and knee. J Am Acad Orthop Surg. 2010;18:771–2.
Workgroup convened by Musculoskeletal Infection Society. New definition for periprosthetic joint infection. J Arthroplast. 2011;26(8):1136.
Parvizi J, Gehrke T. Definition of periprosthetic joint infection. J Arthroplast. 2014;29:1331.
Bingham JS, Salib CG, McQuiey K, Temkit M, Spangehl MJ. An evidence-based clinical prediction algorithm for the musculoskeletal infection society minor criteria. J Athroplasty. 2018;33:2993–6.
Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty: a study of the treatment of one hundred and six infections. J Bone Joint Surg Am. 1996;78:512–23.
Cuckler JM, Star AM, Alavi A, Noto RB. Diagnosis and management of the infected total joint arthroplasty. Orthop Clin North Am. 1991;22:523–30.
Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Osmon DR. Prosthetic joint infection diagnosed postoperatively by intraoperative cultures. Clin Orthop Relat Res. 2005;439:38–42.
Shahi A, Tan T, Kheir MM, Tan DD, Parvizi J. Diagnosing periprosthetic joint infection: and the winner is? J Arthroplast. 2017;32:232–5.
Kim S, Kim J, Jang K, Han S, Lim H, et al. Diagnostic value of synovial white blood cell count and serum c-reactive protein for acute periprosthetic joint infection after knee arthroplasty. J Arthroplast. 2017;32:3724–8.
Yi P, Cross M, Moric M, Sporer S, Berger R, Della VC. Diagnosis of infection in the early postoperative period after total hip arthroplasty. Clin Orthop Relat Res. 2014;472:424–9.
Bedair H, Ting N, Jacovides C, Saxena A, Moric M, Parvizi J, et al. Diagnosis of early postoperative TKA infection using synovial fluid analysis. Clin Orthop Relat Res. 2011;469:34–40.
Shahi A, Deirmengian C, Higuera C, Chen A, Restrepo C, Zmistowski B. Premature therapeutic antimicrobial treatments can compromise the diagnosis of late periprosthetic joint infection. Clin Orthop. 2015;473:2244–9.
Ghanem E, Houssock C, Pulido L, Han S, Jaberi FM, Parvizi J. Determining “true” leukocytosis in bloody joint aspiration. J Arthroplast. 2008;23:182–7.
Parvizi J, Jacovides C, Antoci V, Ghanem E. Diagnosis of periprosthetic joint infection: the utility of a simple yet unappreciated enzyme. J Bone Joint Surg Am. 2011;93:2242–8.
Shahi A, Kheir MM, Tarabichi M, Hosseinzadeh HRS, Tan TL, Parvizi J. Serum D-dimer test is promising for the diagnosis of periprosthetic joint infection and timing of reimplantation. J Bone Joint Surg Am. 2017;99:1419–27.
Parvizi J, Erkocak OF, Della Valle CJ. Culture-negative periprosthetic joint infection. J Bone Joint Surg Am. 2014;96:430–6.
Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH. Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am. 2010;92:2102–9.
Lenski M, Scherer MA. Synovial IL-6 as inflammatory marker in periprosthetic joint infections. J Arthroplast. 2014;29:1105–9.
Stone WZ, Gray CF, Parvataneni HK, Al-Rashid M, Vlasak RG, Horodyski MB, et al. Clinical evaluation of synovial alpha defensin and synovial C-reactive protein in the diagnosis of periprosthetic joint infection. J Bone Joint Surg Am. 2018;100:1184–90.
Plate A, Stadler L, Sutter R, Anagnostopoulos A, Frustaci D, Zbinden R, et al. Inflammatory disorders mimicking periprosthetic joint infections may result in false positive α-defensin. Clin Microbiol Infect. 2018;24(11):1212e1–6.
Goswami K, Parvizi J, Courtney OM. Current recommendations for the diagnosis of acute and chronic PJI for hip and knee—cell counts, alpha-defensin, leukocyte esterase, next-generation sequencing. Curr Rev Musculoskelet Med. 2018;11:428–38.
Maillet M, Pavese P, Bruley D, Seigneurin A, François P. Is prosthesis retention effective for chronic infections in hip arthroplasties? A systematic literature review. Eur J Clin Microbiol Infect Dis. 2015;34:1495–502.
Löwik C, Jutte P, Tornero E, Ploegmakers J, Knobben B, de Vries A, et al. Predicting failure in early acute prosthetic joint infection with debridement, antibiotics, and implant retention: validation of the KLIC score. J Arthroplast. 2018;33:2582–7.
Lizaur-Utrilla A, Gonzalez-Parreño S, Gil-Guillen V, Lopez-Prats FA. Debridement with prosthesis retention and antibiotic therapy vs. two-stage revision for periprosthetic knee infection within 3 months after arthroplasty: a case-control study. Clin Microbiol Infect. 2015;21:851.e11-17.
Zaruta D, Qiu B, Liu A, Ricciardi B. Indications and guidelines for debridement and implant retention for periprosthetic hip and knee infection. Curr Rev Musculoskelet Med. 2018;11:347–56.
Rajgopal A, Panda I, Rao A, Dahiya V, Gupta H. Does prior failed debridement compromise the outcomes of subsequent two-stage revision done for periprosthetic joint infection following total knee arthroplasty? J Arthroplast. 2018;33:2588–94.
Rowan F, Donaldson M, Peitrzak J, Haddad F. The role of one-stage exchange for prosthetic joint infection. Curr Rev Musculoskelet Med. 2018;11:370–9.
Kuiper J, Rustenberg C, Willems J, Verberne S, Peters E, Saouti R. Results and patient reported outcome measures (PROMs) after one-stage revision for periprosthetic joint infection of the hip: a single-center retrospective study. J Bone Jt Infect. 2018;3(3):143–9.
Leonard H, Liddle A, Burke O, Murray D, Pandit H. Single- or two-stage revision for infected total hip arthroplasty? A systematic review of the literature. Clin Orthop Relat Res. 2014;472:1036–42.
Ekpo T, Berend K, Morris M, Adams J, Lombardi A. Partial two-stage exchange for infected total hip arthroplasty: a preliminary report. Clin Orthop Relat Res. 2014;472:437–48.
George J, Miller E, Curtis G, Klika A, Barsoum W, Mont M, et al. Success of two-stage reimplantation in patients requiring an interim spacer exchange. J Arthroplast. 2018;33:S228–32.
Strange S, Whitehouse M, Beswick A, Board A, Board T, Burston A, et al. One-stage or two-stage revision surgery for prosthetic hip joint infection—the INFORM trial: a study protocol for a randomized controlled trial. Trials. 2016;17:90.
Mazzuchelli L, Rosso F, Marmotti A, Bonasia DE, Bruzzone M, Rossi R. The use of spacers (static and mobile) in infection knee arthroplasty. Curr Rev Musculoskelet Med. 2015;8:373–82.
Lichstein P, Su S, Hedlund H, Suh G, Maloney W, Goodman S, et al. Treatment of periprosthetic knee infection with a two-stage protocol using static spacers. Clin Orthop Relat Res. 2016;474:120–5.
Pivec R, Naziri Q, Issa K, Banerjee S, Mont M. Systematic review comparing static and articulating spacers used for revision of infected total knee arthroplasty. J Arthroplast. 2014;29:553–7.e1.
Tan T, Kheir M, Rondon A, Parvizi J, George J, Higuera C, et al. Determining the role and duration of the “antibiotic holiday” period in periprosthetic joint infection. J Arthroplast. 2018;33:2976–80.
Della Valle C, Parvizi J, Bauer T, DiCesare P, Parker Evans R, Segreti J, et al. The diagnosis of periprosthetic infections of the hip and knee: guideline and evidence report. Rosemont: American Academy of Orthopaedic Surgeons; 2010.
Fagotti L, Tatka J, Costa Salles M, Queiroz M. Risk factors and treatment options for failure of a two-stage exchange. Curr Rev Musculoskelet Med. 2018;11:420–7.
Ballard WT, Lowry DA, Brand RA. Resection arthroplasty of the hp. J Arthroplast. 1995;10(6):772–9.
Robinson M, Piponov H, Ormseth A, Helder C, Schwartz B, Gonzalez MH. Knee arthrodesis outcomes after infected total knee arthroplasty and failure of two-stage revision with an antibiotic cement spacer. J Am Acad Orthop Surg Glob Res Rev. 2018;2:e077.
Siqueira M, Saleh A, Klika A, O’Rourke C, Schmitt S, Higuera C, et al. Chronic suppression of periprosthetic infections with oral antibiotics increases infection-free survivorship. J Bone Joint Surg. 2015;97:1220–32.
Prendki V, Sergent P, Barrelet A, Oziol E, Beretti E, Berlioz-Thibal M, et al. Efficacy of indefinite chronic oral antimicrobial suppression for prosthetic joint infection of the elderly: a comparative study. Int J Infect Dis. 2017;60:57–60.
AlBuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br. 2008;90(7):915.
Bratzler DW, Houck PM, Surgical Infection Prevention Guideline Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg. 2005;189(4):395–404.
Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Healthcare Infection Control Practices Advisory Committee. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152(8):784–91.
Yates AJ Jr, American Association of Hip and Knee Surgeons Evidence-Based Medicine Committee. Postoperative prophylactic antibiotics in total joint arthroplasty. Arthroplast Today. 2018;4(1):130–1.
Jacobson C, Osmon DR, Hanssen A, Trousdale RT, Pagnano MW, Pyrek J, et al. Prevention of wound contamination using DuraPrep solution plus Ioban 2 drapes. Clin Orthop Relat Res. 2005;439:32–7.
Bibbo C, Patel DV, Gehrmann RM, Lin SS. Chlorhexidine provides superior skin decontamination in foot and ankle surgery: a prospective randomized study. Clin Orthop Relat Res. 2005;438:204–8.
Johnson AJ, Kapadia BH, Daley JA, Molina CB, Mont MA. Chlorhexidine reduces infections in knee arthroplasty. J Knee Surg. 2013;26(3):213–8.
Ritter MA. Operating room environment. Clin Orthop Relat Res. 1999;369:103–9.
Der Tavitian J, Ong SM, Taub NA, Taylor GJ. Body-exhaust suit versus occlusive clothing. A randomised, prospective trial using air and wound bacterial counts. J Bone Joint Surg Br. 2003;85(4):490–4.
McCue SF, Berg EW, Saunders EA. Efficacy of double-gloving as a barrier to microbial contamination during total joint arthroplasty. J Bone Joint Surg Am. 1981;63(5):811–3.
Al-Maiyah M, Bajwa A, Mackenney P, Port A, Gregg PJ, Hill D, et al. Glove perforation and contamination in primary total hip arthroplasty. J Bone Joint Surg Br. 2005;87(4):556–9.
Knobben BA, van Horn JR, van der Mei HC, Busscher HJ. Evaluation of measures to decrease intra-operative bacterial contamination in orthopaedic implant surgery. J Hosp Infect. 2006;62(2):174–80.
Salvati EA, Robinson RP, Zeno SM, Koslin BL, Brause BD, Wilson PD Jr. Infection rates after 3175 total hip and total knee replacements performed with and without a horizontal unidirectional filtered air-flow system. J Bone Joint Surg Am. 1982;64(4):525–35.
Hooper GJ, Rothwell AG, Frampton C, Wyatt MC. Does the use of laminar flow and space suits reduce early deep infection after total hip and knee replacement?: the ten-year results of the New Zealand Joint Registry. J Bone Joint Surg Br. 2011;93(1):85–90.
Rezapoor M, Alvand A, Jacek E, Paziuk T, Maltenfort MG, Parvizi J. Operating room traffic increases aerosolized particles and compromises the air quality: a simulated study. J Arthroplast. 2018;33(3):851–85.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cohen-Rosenblum, A. et al. (2019). Prosthetic Septic Arthritis: Etiology, Clinical Aspects, and Management. In: Espinoza, L. (eds) Infections and the Rheumatic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-23311-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-23311-2_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23310-5
Online ISBN: 978-3-030-23311-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)